Skip to main content
Latest News
November 19, 2026
Bristol Myers Squibb Demonstrates Breadth and Clinical Momentum Across Blood Cancers and Rare Hematologic Disorders at ASH 2026
November 18, 2026
Bristol Myers Squibb Presents First Clinical Data from Two Phase 3 Studies in the ADEPT Program Evaluating KarXT for Psychosis Associated with Alzheimer’s Disease
November 12, 2026
Bristol Myers Squibb Announces Evolution of Research & Development Organization
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 29, 2026
08:00 AM ET
Bristol Myers Squibb Q3 2026 Results Conference Call
Webcast
(opens in new window)
Press Release (PDF)
Quarterly Package of Financial Information (XLS)
Q3 2026 Results Presentation (PDF)
Q3 2026 Results Presentation (with Appendix)(PDF)
Preliminary Q3 2026 Acquired IPRD & Licensing Income (PDF)
July 30, 2026
08:15 AM ET
Bristol Myers Squibb Q2 2026 Results Conference Call
Webcast
(opens in new window)
Press Release (PDF)
Quarterly Package of Financial Information (XLS)
Q2 2026 Results Presentation (PDF)
Q2 2026 Results Presentation (with Appendix) (PDF)
Preliminary Q2 2026 Acquired IPRD & Licensing Income (PDF)
June 9, 2026
02:00 PM EST
Goldman Sachs 47th Annual Global Healthcare Conference
Webcast
(opens in new window)